Benjamin Pariente

13PUBLICATIONS
22CO-AUTHORS
Foetal development and medicineNephrology and urologyPredictive and prognostic markersEnvironmental epidemiologyOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 21, 2020
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study.

Pauline Wils, Philippe Seksik, Carmen Stefanescu

|Apr 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study.

Aurélien Amiot, Jérôme Filippi, Vered Abitbol

|Mar 30, 2020
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index.

Clémentine Lauriot Dit Prevost, Mustapha Azahaf, Maria Nachury

|Dec 24, 2019
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease.

Parambir S Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet

|Oct 08, 2019
Fine-scale geographical distribution and ecological risk factors for Crohn's disease in France (2007-2014).

Michaël Genin, Mathurin Fumery, Florent Occelli

|Jun 06, 2019
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study.

Aurelien Amiot, Melanie Serrero, Laurent Peyrin-Biroulet

Pageof 3